Conformis, Inc. to Participate in Upcoming Investor Conferences
21 Février 2023 - 10:15PM
Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company
that features personalized knee and hip replacement products,
announced today that Mark Augusti, Chief Executive Officer, and Bob
Howe, Chief Financial Officer, will participate at two upcoming
investor conferences.
March 8 – 43rd Annual
Cowen Healthcare Conference
- The 43rd Annual Cowen Healthcare Conference will take place at
the Boston Marriott Copley Place from March 6-8,
2023.
- Conformis management will participate in a fireside chat on
Wednesday, March 8 from 11:10 a.m. until 11:40 a.m.
EST.
- Webcast: Link to CFMS Fireside Chat at the Cowen
Conference
- Conformis management will also be
available for one-on-one meetings throughout the conference. For
more information about the conference or to schedule a one-on-one
meeting with management, please contact your Cowen representative
or Conformis Investor Relations at ir@conformis.com and (781)
374-5598.
March 14 – 33rd Annual
Oppenheimer Healthcare Conference
- The Oppenheimer 33rd Annual
Healthcare Conference will take place virtually from
March 13-15, 2023.
- Conformis management will present on Tuesday, March 14 from
8:40 a.m. until 9:10 a.m. EST.
- Webcast: Link to CFMS Presentation at the OpCo Conference
- Conformis management will also be
available for one-on-one meetings throughout the conference. For
more information about the conference or to schedule a one-on-one
meeting with management, please contact your Oppenheimer
representative or Conformis Investor Relations at ir@conformis.com
and (781) 374-5598.
A live webcast of each presentation will also be
available under "Events and Presentations" in the Investors section
of the Conformis website at ir.conformis.com. A replay of the
webcast will be archived on Conformis' website for at least 30 days
following the presentation.
About Conformis, Inc.
Conformis is a medical technology company
focused on advancing orthopedic patient care and creating a world
without joint pain. Its product portfolio is designed to maximize
surgeon and patient choice by offering fully personalized solutions
through its Image-to-Implant® Platinum Services℠ Program as well as
data-informed, standardized solutions that combine many benefits of
personalization with the convenience and flexibility of an
off-the-shelf system. Conformis’ sterile, just-in-time,
Surgery-in-a-Box™ delivery system is available with all of its
implants and personalized, single-use instruments. Conformis owns
or exclusively in-licenses issued patents and pending patent
applications that cover personalized implants and patient-specific
instrumentation for all major joints.
For more information, visit www.conformis.com. To receive
future releases in e-mail alerts, sign up at ir.conformis.com.
CONTACT: Investor Relationsir@conformis.com (781)
374-5598
Conformis (NASDAQ:CFMS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Conformis (NASDAQ:CFMS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024